Introduction {#sec1-1}
============

Hypertrophic lichen planus (HLP) is a chronic variant of lichen planus (LP) affecting the skin with an increased risk of developing squamous cell carcinoma (SCC). It presents as thick hyperkeratotic scaly plaques affecting mostly the lower extremities which can mimic SCC. The lesions can as well undergo malignant transformation.\[[@ref1][@ref2]\] We report the case of a 12-year-old boy with history of HLP since 4 years of age who presented with a rapidly progressive ulcer on the right shin since 2 months. It is very uncommon in this age group, most cases being reported in adults.

Case Report {#sec1-2}
===========

A 12-year-old boy presented to us with pruritic hyperpigmented lesions on the legs since 4 years of age. There was a gradual progress in the size of lesion on the right shin with watery discharge since 4 months and ulceration since 2 months. He was treated symptomatically elsewhere with no significant improvement. Cutaneous examination showed multiple hypertrophic plaques ranging in size from 2-4 cms over both shins with central depigmentation and a peripheral margin of hyperpigmentation \[[Figure 1](#F1){ref-type="fig"}\]. A large cauliflower like ulcer 7 × 9 cms in size, non-tender with everted margins and surrounding induration was present over the right shin, over a plaque of LP \[[Figure 2](#F2){ref-type="fig"}\]. The vertical group of inguinal lymph nodes were enlarged, 3 × 3 cms in size, non-tender, mobile, and firm to palpation. Mucosal examination was within normal limits. A wedge biopsy was done from the ulcer along with an inguinal lymph node biopsy. Histopathology revealed a tumor arising from the overlying stratified squamous epithelium arranged in nests and trabeculae and sheets of polygonal cells with pleomorphic vesicular nuclei, dispersed chromatin and visible nucleoli. Keratin pearls were present with tumor infiltration to subcutaneous tissue along with lymphovascular, and focal perineural invasion \[[Figure 3](#F3){ref-type="fig"}\]. Metastatic deposits were seen in 4 deep inguinal lymph nodes with maximum size of tumor deposit being 1 cm. The findings were consistent with moderately differentiated SCC (Grade 2) with inguinal lymph node metastasis. Histopathology of the adjacent hypertrophic skin lesion was consistent with LP. The chest X-ray was normal and CT imaging of abdomen and pelvis did not show deep nodal involvement. He was staged as T3N2M0 (Stage 4). A wide local excision of the ulcer was done with 1-1.5 cms margins on all sides according to the NCCN guidelines 2018 which recommends a margin of more than 1 cm for high risk patients.\[[@ref3]\] A split thickness skin grafting and right ilioinguinal block dissection was also done. The wound site healed rapidly and patient was initiated on local and regional radiotherapy in view of high risk features. He received 60 Gy in 30 fractions over 6 weeks for right inguinal node metastasis. A total of 48 Gy in 16 fractions with surface mold brachytherapy was offered to the right lower leg as well. He was also started on acitretin 10 mg daily for HLP. The ulcer was healing on follow up at 3 months and there were no new LP lesions \[[Figure 4](#F4){ref-type="fig"}\].

![Hypertrophic plaques on the left shin with central depigmentation and a peripheral rim of hyperpigmentation](IDOJ-10-695-g001){#F1}

![Cauliflower like ulcer with everted margins and surrounding induration on the right shin over a plaque of lichen planus](IDOJ-10-695-g002){#F2}

![Well-differentiated tumor mass show prominent keratinization forming pearl like structures with a moderate lymphoplasmacytic infiltrate H and E 40×](IDOJ-10-695-g003){#F3}

![Re-epithelialisation of the ulcer on right shin after grafting and post radiotherapy, at 3 months follow up](IDOJ-10-695-g004){#F4}

Discussion {#sec1-3}
==========

HLP is a T cell mediated chronic variant of lichen planus and the malignant predisposition is controversial. The estimated risk of malignant transformation is 0.4% with less than 50 cases reported in literature till date,\[[@ref1][@ref2][@ref3][@ref4][@ref5]\] youngest being 17 years.\[[@ref6]\] The lag time for developing SCC on cutaneous lesions ranges from 3 months to 40 years. Our patient developed SCC over HLP lesions after a period of 8 years. Besides SCC, keratoacanthomas and verrucous carcinomas have also been reported supporting an association between HLP and keratinocyte malignancies.\[[@ref1]\] A population based study of 2,071 Swedish patients established oral lesions as a precursor of SCC than cutaneous LP.\[[@ref7]\]

The proposed risk factors for malignant transformation include immune alterations, arsenic exposure, chronic tar application and ionizing or ultraviolet radiation treatment.\[[@ref1][@ref8]\] Our patient did not have any risk factors. The long standing non-healing ulcers over LP lesions and long duration of HLP with chronic pruritus further predispose to SCC.\[[@ref8]\] In oral LP, the co-expression of podoplanin and ATP-binding cassette transporter G2 (ABCG2), a transcription factor is a prognostic marker which may indicate the carcinogenic potential of LP.\[[@ref9]\]

Metastatic SCC is extremely rare with only 2 reports till date.\[[@ref8][@ref10]\] Our patient had not taken any treatment for HLP and consulted us nearly 4 months after changes were observed on the cutaneous lesions. This necessitates the importance of treating HLP at an early stage and counseling patients regarding the potential risk of malignancy.

Conclusion {#sec1-4}
==========

To our knowledge this is the youngest reported patient to develop metastatic SCC on longstanding HLP. We would like to emphasize the importance of regular follow up in HLP and periodic biopsies are highly recommended in the presence of danger signs such as sudden increase in size of lesions or ulceration as in our case.
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